Articles

Proteolysis targeting chimeric molecules as therapy for multiple myeloma: efficacy, biomarker and drug combinations

Cedars Sinai Medical Center, Los Angeles, CA, USA
Division of Hematology and Medical Oncology, Oregon Health and Science University Knight Cancer Institute, Portland, OR, USA
Cancer Science Institute of Singapore, National University of Singapore, Singapore
Cancer Science Institute of Singapore, National University of Singapore, Singapore
Cedars Sinai Medical Center, Los Angeles, CA, USA
Cancer Science Institute of Singapore, National University of Singapore, Singapore
Cedars Sinai Medical Center, Los Angeles, CA, USA
Cancer Science Institute of Singapore, National University of Singapore, Singapore
Cedars Sinai Medical Center, Los Angeles, CA, USA
Division of Hematology and Medical Oncology, Oregon Health and Science University Knight Cancer Institute, Portland, OR, USA
Cedars Sinai Medical Center, Los Angeles, CA, USA;Cancer Science Institute of Singapore, National University of Singapore, Singapore
Vol. 104 No. 6 (2019): June, 2019 https://doi.org/10.3324/haematol.2018.201483